New Developments in Medicine and Healthcare
Breakthroughs in brain-computer interfaces, obesity treatment, and concerns over price hikes in asthma medication
Read latest briefing →⚕️ Desk
Health, Medicine, Wellness and healthcare developments
Breakthroughs in brain-computer interfaces, obesity treatment, and concerns over price hikes in asthma medication
Read latest briefing →Desk archive
Bayer sues J&J over claims that its prostate cancer treatment is more effective, citing flawed data and false advertising; lawsuit seeks damages and corrective action.
New pathway expected to spur applications for rare disease treatments
Setbacks for lung disease, puberty blockers, and cancer blood test studies
Scientists develop a simple test to predict onset of memory loss
Gilead Sciences is buying Arcellx for $7.8 billion, expanding its CAR-T therapy portfolio, while Novo Nordisk's next-gen obesity drug underperformed in a comparison study.
As the midterms approach, health care is in the spotlight, with lobbyists targeting the FDA, AI devices potentially bypassing review, and reform efforts facing an uphill battle.
Gaps in regulation and oversight leave vulnerable individuals exposed to harm
From CAR-T treatments to cold weather's impact on heart health, here's what's new in the world of health and science
A university student's survival story and the latest on TrumpRx and biotech breakthroughs
Experts weigh in on FDA influence, China's rise, and the future of medical innovation
Updates on statins, vaccines, and vaping policies stir debate and discussion
New research on colon cancer, COVID-19, and AI toys raises concerns and hopes
A "mirror-image" molecule has been found to dramatically slow the growth of certain cancers while leaving healthy cells largely untouched.
This week saw several significant developments in the fields of science, health, and community building.
Patients suffer as hospitals reap billions in revenue from 340B program
Some pharmaceutical companies' most-favored nation drug pricing deals with the Trump administration are expiring after three years, leaving their future pricing strategies uncertain.
Experts warn of potential consequences for mental and physical well-being
The pharmaceutical industry is undergoing a period of significant change, with numerous high-profile hires, departures, and promotions across various companies, signaling a shifting landscape in the sector.
FDA Commissioner Marty Makary defends the agency's recent rejections of rare disease drugs, amid criticism from patient advocates and lawmakers.
Parents of two-year-old with life-limiting epilepsy left exhausted and desperate
Influenza vaccine composition recommendations released and Denmark eliminates mother-to-child transmission of HIV and syphilis
New innovations and discoveries bring relief to families and individuals
The US Department of Justice has weighed in on a dispute between AbbVie and the state of Colorado, backing the pharmaceutical company's bid to overturn a law guiding the 340B drug discount program.